Form 8-K · Current report
Aptiv 8-K, filed Aug 4, 2026
- Filed
- CIK
- 0001521332
- Accession no.
- 0001521332-26-000057
Summary
Aptiv reported second-quarter 2026 revenue of $3.3 billion, up 2%, with net income from continuing operations of $298 million, or $1.40 per diluted share, and adjusted earnings per share of $1.63. The company, which completed the April 1 spin-off of its Electrical Distribution Systems segment into Versigent and received a $1.9 billion dividend, issued third-quarter and full-year 2026 guidance.
Key points
- Second-quarter adjusted EBITDA was $613 million, with an 18.7% margin, compared with $547 million and 17.1% a year earlier.
- Aptiv redeemed $1.847 billion of senior notes in April 2026, principally using proceeds from the Versigent cash distribution.
- Aptiv repurchased and retired 4.1 million shares for $250 million in the second quarter, bringing year-to-date repurchases to $325 million.
- Full-year 2026 guidance projects net sales of $12.6 billion to $12.8 billion and adjusted earnings per share of $5.60 to $5.80.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
From the filing
Item 2.02 Results of Operations and Financial Condition. On August 4, 2026, Aptiv PLC (the “Company”) issued a press release reporting its financial results for the quarter ended June 30, 2026. A copy of the press release is attached as an exhibit and is incorporated herein by reference. The press release and teleconference visual presentation are available on the Company’s website at aptiv.com. The information in this Item 2.02 and Item 9.01, including Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.